Identification of novel pathogenic gene and genotype phenotype correlation in peroxisome biogenesis disorders
Identification of novel pathogenic gene and genotype phenotype correlation in peroxisome biogenesis disorders
批准号:
15570100
负责人:
TAMURA Shigehiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The human disorders of peroxisome biogenesis (PBDs) are subdivided into 12 complementation groups(CGs). CG8 is one of the more common of these and is associated with varying phenotypes, ranging from the most severe, Zellweger syndrome(ZS), to the milder neonatal adrenoleukodystrophy(NALD) and infantile Refsum disease(IRD). PEX26, encoding the 305-amino-acid membrane peroxin, has been shown to be deficient in CG8. We studied the PEX26 genotype in fibroblasts of eight CG8 patientsfour with the ZS phenotype, two with NALD, and two with IRD. Catalase was mostly cytosolic in all these cell lines, but import of the proteins that contained PTS1, the SKL peroxisome targeting sequence, was normal. Expression of PEX26 reestablished peroxisomes in all eight cell lines, confirming that PEX26 defects are pathogenic in CG8 patients. When cells were cultured at 30℃, catalase import was restored in the cell lines from patients with the NALD and IRD phenotypes, but to a much lesser extent in those with the ZS phenotype, indicating that temperature sensitivity varied inversely with the severity of the clinical phenotype. Several types of mutations were identified, including homozygous G89R mutations in two patients with ZS. Expression of these PEX26 mutations in pex26 Chinese hamster ovary cells resulted in cell phenotypes similar to those in the human cell lines. These findings confirm that the degree of temperature sensitivity in pex26 cell lines is predictive of the clinical phenotype in patients with PEX26 deficiency.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The novel pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes.
新型致病性过氧化物蛋白 Pex26p 将 Pex1p-Pex6p AAA ATP 酶复合物募集到过氧化物酶体中。
DOI:
--
发表时间:
2003
期刊:
Nat.Cell Biol. 5
影响因子:
--
作者:
[Matsumoto, N. et al.]
通讯作者:
N. et al.
Matsumoto, N.: "The novel pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA-ATPase complexes to peroxisomes"Nat.Cell Biol. 5. 454-460 (2003)
Matsumoto, N.:“新型致病性过氧化物蛋白 Pex26p 将 Pex1p-Pex6p AAA-ATP 酶复合物招募到过氧化物酶体”Nat.Cell Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
The novel pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA-ATPase complexes to peroxisomes.
新型致病性过氧化物蛋白 Pex26p 将 Pex1p-Pex6p AAA-ATP 酶复合物招募到过氧化物酶体中。
DOI:
--
发表时间:
2003
期刊:
Nat.Cell Biol. 5
影响因子:
--
作者:
[Matsumoto, N. et al.]
通讯作者:
N. et al.
Matsumoto, N.: "Mutations in novel peroxin gene PEX26 that cause peroxisome biogenesis disorders of complementation group 8 provide a genotype phenotype correlation."Am.J.Hum.Genet.. 73. 233-246 (2003)
Matsumoto, N.:“新型过氧化物酶基因 PEX26 中的突变导致互补组 8 的过氧化物酶体生物发生障碍,提供了基因型表型相关性。”Am.J.Hum.Genet.. 73. 233-246 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1086/377004
发表时间:
2003-08-01
期刊:
AMERICAN JOURNAL OF HUMAN GENETICS
影响因子:
9.8
作者:
[Matsumoto, N, Tamura, S, Fujiki, Y]
通讯作者:
Fujiki, Y
Identification of core components of peroxisomal membrane translocator
-
批准号:24570134
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.58万
-
财政年份:2012
-
负责人:TAMURA Shigehiko
-
依托单位:
Roles of AAA peroxins in peroxisome biogenesis
-
批准号:21570116
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:TAMURA Shigehiko
-
依托单位:
A new approach for the AAA peroxin research
-
批准号:18570111
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.59万
-
财政年份:2006
-
负责人:TAMURA Shigehiko
-
依托单位:
Identification of novel PEX gene and functional analysis of Pexlp in peroxisome biogenesis
-
批准号:13680694
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:TAMURA Shigehiko
-
依托单位:
Studies on Perxisome Biogenesis and Function of Pex1p
-
批准号:11680608
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TAMURA Shigehiko
-
依托单位:
海外基金